Salarius Pharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2020 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Salarius Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2020 to Q2 2024.
  • Salarius Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 600K shares, a 77.3% increase year-over-year.
  • Salarius Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 3.26M shares, a 53.7% increase from 2022.
  • Salarius Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 2.12M shares, a 28.4% increase from 2021.
  • Salarius Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 1.65M shares, a 89.4% decline from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 600K +262K +77.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 4.19M +1.8M +75.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 3.26M +1.14M +53.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-22
Q3 2023 3.75M +1.51M +67% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 339K -1.8M -84.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 2.39M +542K +29.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 2.12M +470K +28.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-22
Q3 2022 2.25M +456K +25.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 2.14M -42.6M -95.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 1.85M -28.7M -93.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 1.65M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-27
Q3 2021 1.79M -16.2M -90% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 44.8M +30.8M +221% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 30.6M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 18M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 14M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.